Board of Directors

Dr. Martin Roland Jensen – Chairman

Education: Dr. Martin Roland Jensen holds a Master of Science, and PhD. Molecular and Cellular biology from University of Copenhagen, Denmark.

Previous assignments/engagements: Dr. Martin Roland Jensen has extensive leadership experience from the biopharmaceutical industry and has as serial entrepreneur founded and co-founded several biotech companies. He also has extensive experience with scientific work, mainly in immunology, cell biology and development of cancer vaccines. Dr. Martin Roland Jensen is one of the co-founders of the Company.

Other material ongoing positions: Founder and CEO of Medic-Advice ApS and Martin Roland Holding ApS. Co-founder, Chairman of the Board and CBO in Cell2Cure ApS, and Co-founder in Unikum Therapeutics ApS. Martin is also Chairman of the Board in
ExpreS2ion Biotechnologies ApS.

Shares: Dr. Jensen owns 645,857 shares in ExpreS2ion Biotech Holding AB. Of these, he owns 501,841 shares through his holding company Martin Roland Holding ApS, 89,580 shares through his holding company Medic-Advice Holding ApS, and 54,436 shares privately.

Warrants: 51,608


Jakob Knudsen – Board Member

Education: Jakob Knudsen holds a Master of Law from the University of Copenhagen, DK, and an MBA from Imperial College, UK.

Previous assignments/engagements: Jakob Knudsen has built up extensive experience in commercial operations, including business development, marketing and finance. He has held various positions at ALK-Abelló A/S, a listed mid-sized biotechnology company in Denmark, where he a.o. headed Corporate Business Development. Furthermore, he has held positions as CCO and CFO at the Danish pharmaceutical company Egalet Ltd.

Other material ongoing positions: CEO and Member of the Board of Management of ViroGates A/S (Nasdaq First North Growth Market CPH ”VIRO”) an in-vitro diagnostic commercial company. Jakob is a Board Member in ExpreS2ion Biotechnologies ApS, Ingeniørsystem A/S and PV Fonden.

Mr. Knudsen is an independent member of the board.

Shares: 18,940

Warrants: 10,940

Karin Garre – Board Member

Education: Karin Garre holds a Doctor of Medicine from Copenhagen University, Denmark.

Previous assignments/engagements: Karin Garre has extensive leadership, change management and drug development experience from over 30 years in life science, both in the pharmaceutical and biotech industries such as Astra A/S, Novo Nordisk A/S, and Genmab, where she served in either line or corporate functions. Karin Garre also was Executive Head of Center of Capital Region of Copenhagen.

Other material ongoing positions: General Manager and Head of Symphogen A/S. Karin is a Board Member in Cervello A/S and ExpreS2ion Biotechnologies ApS.

Dr. Karin Garre has been an independent member of the board since May 2021.

Shares: None

Warrants: None

Sara Sande – Board Member

Education: Sara Sande holds a Master of Science in Economics from University of Copenhagen, Denmark.

Prior positions/experience: Sara Sande has extensive leadership and top management experience from high-tech B2B companies. Sara Sande was Vice President of Cooper Surgical and Head of Grain & Beverages Sales, Europe of Novozymes.

Other material ongoing positions: Sara is a Board Member in Agreena ApS, Biosyntia ApS, Cirqle ApS, ExpreS2ion Biotechnologies ApS, Hydract A/S and Reduce ApS, and board observer in Cellugy ApS and Chromologics ApS. Furthermore, Sara is Investment Director of Danmarks Eksport og Investeringsfond.

Sara Sande has been an independent member of the board since May 2021.

Shares: 6,220

Warrants: 2,220